Open Internet by MindsNet

Overcoming TIGIT Pathway Inhibition Failures in Cancer Treatment

The TIGIT pathway has been a challenging target for cancer treatment, with multiple therapies failing to deliver clinically meaningful results. Despite its promise in disrupting immunosuppressive effects, therapies targeting TIGIT have consistently underperformed in clinical trials. This has led to significant investment losses and discontinued partnerships.

Science, Medicine, Pharmacology